AMGEN INCAMGN

Market cap

$175.3B

P/E ratio

	Dec 31, 2010	Dec 31, 2011	Dec 31, 2012	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Product sales	-	-	-	-	-	-	-	-	-	-	-	24,297	24,801	26,910	32,026
Other revenues	-	-	-	-	-	-	-	-	-	-	1,184	1,682	1,522	1,280	1,398
Total revenues	-	-	-	-	-	-	-	-	-	-	-	25,979	26,323	28,190	33,424
Cost of sales	-	-	-	-	-	-	-	-	4,101	4,356	6,159	6,454	6,406	8,451	12,858
Research and development	2,894	3,167	3,380	4,083	4,297	4,070	3,840	3,562	3,737	4,116	4,207	4,819	4,434	4,784	5,964
Selling, general and administrative	3,983	4,486	4,801	5,184	4,699	4,846	5,062	4,870	5,332	5,150	5,730	5,368	5,414	6,179	7,096
Other	117	896	295	196	454	49	133	375	314	66	189	194	503	879	248
Total operating expenses	9,508	11,270	11,688	12,809	13,872	13,192	13,197	12,876	13,484	13,688	16,285	18,340	16,757	20,293	26,166
Operating income	5,545	4,312	5,577	5,867	6,191	8,470	9,794	9,973	10,263	9,674	9,139	7,639	9,566	7,897	7,258
Interest expense, net	604	610	1,053	1,022	1,071	1,095	1,260	1,304	1,392	1,289	1,262	1,197	1,406	2,875	3,155
Other income (expense), net	376	448	485	420	465	603	629	928	674	753	256	259	-814	2,833	506
Income before income taxes	5,317	4,150	5,009	5,265	5,585	7,978	9,163	9,597	9,545	9,138	8,133	6,701	7,346	7,855	4,609
Provision for income taxes	690	467	664	184	427	1,039	1,441	7,618	1,151	1,296	869	808	794	1,138	519
Net income	4,627	3,683	4,345	5,081	5,158	6,939	7,722	1,979	8,394	7,842	7,264	5,893	6,552	6,717	4,090
Basic (in usd per share)	4.82	4.07	5.61	6.75	6.8	9.15	10.32	2.71	12.7	12.96	12.4	10.34	12.18	12.56	7.62
Diluted (in usd per share)	4.79	4.04	5.52	6.64	6.7	9.06	10.24	2.69	12.62	12.88	12.31	10.28	12.11	12.49	7.56